• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肾类器官的全基因组筛选确定了肾发生的发育和疾病相关方面。

Genome-wide screening in human kidney organoids identifies developmental and disease-related aspects of nephrogenesis.

机构信息

Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.

Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.

出版信息

Cell Stem Cell. 2022 Jan 6;29(1):160-175.e7. doi: 10.1016/j.stem.2021.11.001. Epub 2021 Nov 29.

DOI:10.1016/j.stem.2021.11.001
PMID:34847364
Abstract

Human organoids allow the study of proliferation, lineage specification, and 3D tissue development. Here we present a genome-wide CRISPR screen in induced pluripotent stem cell (iPSC)-derived kidney organoids. The combination of inducible genome editing, longitudinal sampling, and endpoint sorting of tubular and stromal cells generated a complex, high-quality dataset uncovering a broad spectrum of insightful biology from early development to "adult" epithelial morphogenesis. Our functional dataset allows improving mesoderm induction by ROCK inhibition, contains monogenetic and complex trait kidney disease genes, confirms two additional congenital anomalies of the kidney and urinary tract (CAKUT) genes (CCDC170 and MYH7B), and provides a large candidate list of ciliopathy-related genes. Finally, identification of a cis-inhibitory effect of Jagged1 controlling epithelial proliferation shows how mosaic knockouts in pooled CRISPR screening can reveal ways of communication between heterogeneous cell populations in complex tissues. These data serve as a rich resource for the kidney research community and as a benchmark for future iPSC-derived organoid CRISPR screens.

摘要

人类类器官允许研究增殖、谱系特化和 3D 组织发育。在这里,我们在诱导多能干细胞 (iPSC) 衍生的肾类器官中进行了全基因组 CRISPR 筛选。诱导性基因组编辑、纵向采样和管状和基质细胞的终点分选的结合,生成了一个复杂的高质量数据集,揭示了从早期发育到“成年”上皮形态发生的广泛的有见地的生物学。我们的功能数据集允许通过 ROCK 抑制来改善中胚层诱导,包含单基因和复杂特征肾脏疾病基因,证实了另外两个肾脏和尿路先天性异常 (CAKUT) 基因 (CCDC170 和 MYH7B),并提供了大量与纤毛病相关的候选基因列表。最后,Jagged1 控制上皮增殖的顺式抑制作用的鉴定表明,在汇集的 CRISPR 筛选中,嵌合体敲除如何揭示复杂组织中异质细胞群体之间的通讯方式。这些数据为肾脏研究界提供了丰富的资源,并为未来的 iPSC 衍生类器官 CRISPR 筛选提供了基准。

相似文献

1
Genome-wide screening in human kidney organoids identifies developmental and disease-related aspects of nephrogenesis.人类肾类器官的全基因组筛选确定了肾发生的发育和疾病相关方面。
Cell Stem Cell. 2022 Jan 6;29(1):160-175.e7. doi: 10.1016/j.stem.2021.11.001. Epub 2021 Nov 29.
2
A Toolbox to Characterize Human Induced Pluripotent Stem Cell-Derived Kidney Cell Types and Organoids.用于鉴定人诱导多能干细胞衍生的肾细胞类型和类器官的工具包。
J Am Soc Nephrol. 2019 Oct;30(10):1811-1823. doi: 10.1681/ASN.2019030303. Epub 2019 Sep 6.
3
Reporter-based fate mapping in human kidney organoids confirms nephron lineage relationships and reveals synchronous nephron formation.基于报道者的人类肾类器官命运图谱分析确认了肾单位谱系关系,并揭示了同步的肾单位形成。
EMBO Rep. 2019 Apr;20(4). doi: 10.15252/embr.201847483. Epub 2019 Mar 11.
4
Rapid target validation in a Cas9-inducible hiPSC derived kidney model.在 Cas9 诱导的 hiPSC 衍生肾模型中快速进行靶标验证。
Sci Rep. 2021 Aug 16;11(1):16532. doi: 10.1038/s41598-021-95986-5.
5
Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids.使用基因编辑技术对来源于成体干细胞和诱导多能干细胞(iPSC)的类器官进行建模,以模拟胰腺病理生理学。
Am J Physiol Gastrointest Liver Physiol. 2021 Jun 1;320(6):G1142-G1150. doi: 10.1152/ajpgi.00329.2020. Epub 2021 Mar 24.
6
Embryonic Stem Cells Derived Kidney Organoids as Faithful Models to Target Programmed Nephrogenesis.胚胎干细胞衍生的肾脏类器官作为靶向编程性肾发生的忠实模型。
Sci Rep. 2018 Nov 9;8(1):16618. doi: 10.1038/s41598-018-34995-3.
7
Microplastics exposure disrupts nephrogenesis and induces renal toxicity in human iPSC-derived kidney organoids.微塑料暴露会破坏肾发生并诱导人诱导多能干细胞衍生的肾类器官的肾毒性。
Environ Pollut. 2024 Nov 1;360:124645. doi: 10.1016/j.envpol.2024.124645. Epub 2024 Jul 31.
8
Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis.人诱导多能干细胞来源的肾类器官包含多种细胞谱系,并可模拟人类肾发生。
Nature. 2015 Oct 22;526(7574):564-8. doi: 10.1038/nature15695. Epub 2015 Oct 7.
9
Forward steps in organoid-based forward screening.基于类器官的正向筛选的前进步骤。
Cell Stem Cell. 2022 Jan 6;29(1):7-8. doi: 10.1016/j.stem.2021.12.004.
10
Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.长期扩增的小鼠和人诱导的肾祖细胞可使肾类器官成熟,并对可塑性和疾病进行建模。
Cell Stem Cell. 2024 Jun 6;31(6):921-939.e17. doi: 10.1016/j.stem.2024.04.002. Epub 2024 Apr 30.

引用本文的文献

1
Perturbomics: CRISPR-Cas screening-based functional genomics approach for drug target discovery.扰动组学:基于CRISPR-Cas筛选的药物靶点发现功能基因组学方法。
Exp Mol Med. 2025 Jul 1. doi: 10.1038/s12276-025-01487-0.
2
From Genes to Environment: Elucidating Pancreatic Carcinogenesis Through Genetically Engineered and Risk Factor-Integrated Mouse Models.从基因到环境:通过基因工程和风险因素整合小鼠模型阐明胰腺癌发生机制
Cancers (Basel). 2025 May 15;17(10):1676. doi: 10.3390/cancers17101676.
3
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.
上下文依赖的表观遗传和器官发生程序决定了MYC驱动的小鼠肝癌细胞的三维与二维细胞适应性。
Elife. 2025 May 6;14:RP101299. doi: 10.7554/eLife.101299.
4
Imaging 3D cell cultures with optical microscopy.用光学显微镜对3D细胞培养物进行成像。
Nat Methods. 2025 Apr 17. doi: 10.1038/s41592-025-02647-w.
5
Integration of Organoids With CRISPR Screens: A Narrative Review.类器官与CRISPR筛选技术的整合:一篇综述
Biol Cell. 2025 Apr;117(4):e70006. doi: 10.1111/boc.70006.
6
Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient.个体化的CRISPR/Cas9联合筛选确定CDK2是一例犬乳腺癌患者的可药物靶向弱点。
Vet Sci. 2025 Feb 18;12(2):183. doi: 10.3390/vetsci12020183.
7
Organoids as Sophisticated Tools for Renal Cancer Research: Extensive Applications and Promising Prospects.类器官作为肾癌研究的精密工具:广泛应用与广阔前景
Cell Mol Bioeng. 2024 Oct 15;17(6):527-548. doi: 10.1007/s12195-024-00825-y. eCollection 2024 Dec.
8
Appraisal of CRISPR Technology as an Innovative Screening to Therapeutic Toolkit for Genetic Disorders.CRISPR技术作为遗传疾病创新筛查和治疗工具的评估。
Mol Biotechnol. 2025 Feb 2. doi: 10.1007/s12033-025-01374-z.
9
Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes.用于人类蛋白质编码基因全基因组激活、缺失和沉默的阵列式CRISPR文库。
Nat Biomed Eng. 2025 Jan;9(1):127-148. doi: 10.1038/s41551-024-01278-4. Epub 2024 Dec 4.
10
Epigenetics of Hypertensive Nephropathy.高血压肾病的表观遗传学
Biomedicines. 2024 Nov 16;12(11):2622. doi: 10.3390/biomedicines12112622.